Concepedia

Priyank Kumar

PK

10

Publications

409

Citations

10

H-Index

2007

Active since

Affiliations

St. John's University(Current)

Key Laboratory of Guangdong Province

State Key Laboratory of Oncology in South China

Sun Yat-sen University

Sun Yat-sen University Cancer Center

Priyank Kumar is an author at St. John's University specializing in medicine, pharmacology, and molecular pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryDrug ResistancePharmacotherapyMolecular PharmacologyCell BiologyTumor BiologyCancer ResearchHealth

Publications per year

2007–2017

10

Publications

10

Autophagy and Transporter-Based Multi-Drug Resistance

Priyank Kumar, Dongmei Zhang, Kurt Degenhardt et al. · Cells · 2012 · 71 citations · Full text

Mitophagy, Apoptosis, Cell Death +18

Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of μ-opioid receptors and dynamin-2

Mohit Pawar, Priyank Kumar, Soujanya Sunkaraneni et al. · European Journal of Pharmacology · 2007 · 56 citations · Full text

Molecular Pharmacology, Opioid Agonist Efficacy, Addiction +9

Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1

Yi‐Jun Wang, Rishil J. Kathawala, Yunkai Zhang et al. · Biochemical Pharmacology · 2014 · 55 citations · Full text

Inhibitory Activity, Efflux Activity, Biochemistry +11

Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo

Kamlesh Sodani, Atish Patel, Nagaraju Anreddy et al. · Biochemical Pharmacology · 2014 · 47 citations · Full text

Molecular Pharmacology, Drug Targeting, Novel Therapy +9

Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar

Yue-Li Sun, Jun-Jiang Chen, Priyank Kumar et al. · PLoS ONE · 2013 · 46 citations · Full text

Chemoprevention Strategy, Multidrug Resistance, Pharmacotherapy +20

Rows per page

1–5 of 10